Objective: To provide clinical data on a cohort of 6 patients with massive expansion (Ͼ200 CAG repeats) of spinocerebellar ataxia type 2 (SCA2) and investigate possible pathways of pathogenesis using bioinformatics analysis of ATXN2 networks.
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disease associated with expansion of a CAG repeat in ATXN2. 1 An expansion size of 33-64 repeats results in adult onset of slowly progressive ataxia, dysarthria, and eye movement abnormalities. 2 Other phenotypes in adults have included retinitis pigmentosa (RP), [3] [4] [5] autonomic disturbance, 6 hypogonadotropic hypogonadism, 7 and mixed ataxia-parkinsonism. 8, 9 There are reports of childhood-onset SCA2 with expansions of 62-75 repeats, 10 -13 and in some families variation in CACNA1A modifies age of onset. 14 Moderate-sized expansion in ATXN2 results in Purkinje cell degeneration through cellular dysfunction on multiple levels, [15] [16] [17] and may include abnormalities in RNA binding and splicing. 18 Mice with polyQ-58 mutations in Atxn2 have Purkinje cell degeneration similar to that seen in patients with adult-onset SCA2. 19 Interestingly, knockout mice deficient in Atxn2 are obese and have abnormal fear conditioning, but have normal neurohistology. 20 A single pediatric patient report associated massive expansion (Ͼ200 repeats) of SCA2 with progressive encephalopathy, optic atrophy, RP, and early death. 21 We present data on 5 additional patients, including updated clinical information on the patient previously reported. All had massive expansion of SCA2 with cortical and cerebellar degeneration, 4 had RP, 3 had infantile spasms (ISS), and 2 others had infant-onset epilepsy. We then used bioinformatics tools to generate hypotheses about mechanisms of pathogenesis. Given the interaction of ATXN2 with a synaptic proteinprotein network 18 that includes A2BP1, 22 and the association of A2BP1 with epilepsy and autism, 23, 24 we asked whether a network relationship might exist between the ATXN2 network, the identified genetic causes of RP, the newly described genes associated with ISS, and other pathways of synaptic function. We hypothesize that the severe phenotype of patients with massive expansion of SCA2 may be due to a functional deficit in key proteinprotein networks in the postsynapse.
METHODS Patients.
Retrospective records from 6 patients with massive expansion of SCA2 were reviewed, including EEG reports, brain imaging, and histopathology. Analysis of the SCA2 alleles was carried out as described 1 with additional modifications. 25 Standard protocol approvals, registrations, and patient consents. The study was approved by the institutional review board of the University of Chicago.
Bioinformatic analyses. Role of ATXN2 network in brain development and function. The genes in the ATXN2 interaction network were investigated for evidence of brain expression and role in brain development and function using publicly available Web-based resources, as detailed in appendix e-1 on the Neurology ® Web site at www.neurology.org.
Network analysis. The genes in the ATXN2 interaction network were next combined with 1) a list of genes associated with RP; 2) a list of genes associated with ISS; and, given the known interactions between ATXN2 and synaptic proteins, 3) a list of genes involved in synaptic function. Each combined list was then examined with a network analysis algorithm to look for evidence of interactions between the ATXN2 network and genes/proteins associated with RP, ISS, and synaptic function, as detailed in appendix e-1.
RESULTS Patient 1. This infant girl was previously reported. 21 She presented with apnea at 2 weeks. Occipital-frontal circumference (OFC) was Ϫ3 SD at 10 months of age. Ophthalmologic examination showed RP. SCA2 testing revealed an abnormal allele with 220 CAG repeats. However, one aspect of her case not known to the authors of the initial report was that she developed ISS at 16 months, with hyp-sarrhythmia on EEG. She died at 2 years from respiratory complications. Patient 2. This infant girl presented with hypotonia at 6 months. MRI at 7 months (figure 1, A and B) showed probable cerebellar atrophy and delayed myelination. At 14 months she developed ISS with hypsarrhythmia. She had relative microcephaly (length 25th percentile, OFC Ϫ2 SD) and optic nerve atrophy. Repeat brain MRI at 17 months (figure 1, C and D) showed cerebral dysmyelination, enlarged lateral ventricles, and obvious cerebellar and brainstem atrophy. SCA2 testing showed CAG repeat size of Ͼ200. She had autonomic dysfunction, and died at 22 months from aspiration pneumonia. Patient 3. This infant boy presented at 3 months with focal seizures. At 10 months he developed ISS with hypsarrhythmia. Brain MRI at 10 months showed prominent sulci frontally, enlargement of the lateral and third ventricles, and an atrophic-appearing cerebellum (not shown). At 12 months he was microcephalic, with sluggish pupillary reaction to light. Ophthalmologic examination diagnosed cortical visual impairment, and otoacoustic emissions were absent. He had impaired swallowing and autonomic instability. SCA2 testing showed a repeat length of Ͼ200. He died at 13 months. Patient 4. This infant girl presented with loss of head control and poor visual fixation at 3 months and at 5 months she had myoclonic seizures. At 17 months EEG showed high-amplitude bursts of slow waves with polyspikes reminiscent of hypsarrhythmia. Brain MRI at 6 months showed diffuse parenchymal volume loss and delayed myelination (figure 1, G and H). She was microcephalic (OFC Ϫ3 SD) and by 21 months was somnolent with minimal visual interaction. Ophthalmologic examination showed RP. SCA2 testing showed an expanded allele with Ͼ500 CAG repeats. She died at 32 months. Pathologic examination of the cerebellum showed reduction in the thickness of the molecular layer, but relative preservation of both Purkinje and granular neurons ( figure 2A ). Patient 5. This infant girl was the paternal half-sister of patient 4. She had global developmental delay in infancy and was reported to be microcephalic (OFC not available). At 4 years she was failing to thrive with poorly coordinated swallow and 10 months later began to lose motor and cognitive milestones and had autonomic dysfunction. Brain MRI at 5 years 10 months (figure 1, I and J) showed diffuse T2 white matter signal abnormalities, with cavitations of the parieto-occipital lobes and cortical and cerebellar volume loss. Ophthalmologic examination revealed optic nerve atrophy and RP. Initial SCA2 testing was negative, but was repeated due to suspicion that routine PCR amplification may not detect very large expansions, with discovery of a median CAG repeat length of 750. Patient 6. This infant girl presented at 2 months with poor head control and lack of visual fixation. At 7 months she had tonic seizures. An EEG at 14 months showed multifocal epileptiform discharges. At 12 months she was diagnosed with RP. Brain MRI at 12 months (figure 1, K and L) showed mild cerebellar atrophy. At 13 months a gastrostomy tube was placed. SCA2 testing showed 300 CAG repeats. The patient died after a neurodegenerative course. Pathologic examination of the cerebellum showed pro-found loss of Purkinje and granular neurons with severe attenuation of the molecular layer ( figure 2B) . The data on all 6 patients are summarized in table 1.
Bioinformatic analyses. Role of ATXN2 network in brain development and function. The evidence for each gene in the ATXN2 network for a role in brain development and function is shown in table e-1 (see appendix e-1). This analysis validated the importance of several members of the ATXN2 network in gene ontology (GO) categories important for neurologic development and function. 18, 26 Network analysis. Analysis of the genes in the ATXN2 network combined with genes associated with RP did not reveal any direct interactions (data not shown). However, a network relationship be- tween ATXN2 and SYNJ1 suggests a possible mechanism for retinal dysfunction in patients with expansion of SCA2. As several patients in this series had ISS, we also looked for interactions between the ATXN2 network and the genes associated with ISS. A network was found between ATXN2, SYNJ1, PTEN, MAGI2, and SPTAN1 ( figure 3) . MAGI2 is expressed postsynaptically, as is ACTN2, a key member of the ATXN2 network. 27, 28 ACTN2 forms part of an interaction network with the spectrin protein SPTAN1, mutations of which have recently been described in children with ISS. 29 We then analyzed the ATXN2 network together with proteins involved in synaptic function, in order to discover additional interactions potentially involved in pathogenesis. Our analysis identified additional interactions between ATXN2 and SH3GL2, a member of the GO biological process of synaptic vesicle transport.
DISCUSSION Massive expansion of SCA2 is associated with a severe neurologic phenotype, with hypotonia and global developmental delay in the first year of life. Four of the patients in this report had RP, which has been described in some patients with moderate-sized SCA2 expansions as well. Our bioinformatics analysis identified a hypothetical network relationship between ATXN2 and SYNJ1. Synj1 has a role in zebrafish retinal function, specifically in cone photoreceptors, 30, 31 and it is possible that impaired ATXN2-SYNJ1 interactions play a role in the development of RP in patients with expanded SCA2 alleles. Three of the patients developed ISS, and one of the others had infant-onset myoclonic seizures with an EEG with elements of hypsarrhythmia. As ISS can be associated with mutations in genes with roles in forebrain development, specifically synaptic function, 29, [32] [33] [34] [35] we focused our bioinformatics analysis on discovery of further interactions between the ATXN2 network and proteins important in synapse biology. Previous work on the ATXN2 network 18, 26 supported this approach, and we report additional possible interactions between ATXN2 and proteins involved in synaptic vesicle endocytosis, including SH3KBP1, SYNJ1, DNM1, and AMPH. SYNJ1 has an additional role in postsynaptic AMPA regulation, 36 and through interaction with PTEN connects to MAGI2, an anchoring molecule in the postsynaptic density associated with ISS. It remains unclear why children with massive expansions in SCA2 have a more severe phenotype than patients with more moderate-sized expansions. The mechanism may involve a toxic effect of messenger RNA containing the expansion and impairment of key cellular survival pathways, similar to that found in myotonic dystrophy type 1. 37, 38 We specu-late that this pathway dysfunction may be most deleterious at the synapse. Further study will also be needed to clarify the variable clinical and neuropathologic spectrum seen in this disorder.
We report a severe neurologic phenotype in a group of 6 patients with massive expansion of SCA2. We used a bioinformatics approach to generate the hypothesis that a functional deficit in several important protein networks in the postsynapse may be involved in pathogenesis. This hypothesis can be tested in the repeat expansion mouse model of SCA2, with more severe phenotypes expected to correlate with abnormal expression patterns of proteins in the postsynapse.
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Figure 3
Postsynaptic protein-protein interaction network, showing relationship between ATXN2 (yellow) and SYNJ1 (blue) via SH3GL2 and SH3KBP1 SYNJ1 in turn has a relationship with PTEN. The postsynaptic proteins associated with infantile spasms, MAGI2 (orange) and SPTAN1 (red), form a subnetwork that in turn interacts with PTEN. Figure generated by STRING 8.3 with 0.9 confidence level.
